Dr. Reddy's Laboratories Ltd. closed 7.22% short of its 52-week high of 1,420.20 rupees, which the company achieved on August ...

Discover the Dr Reddys Stock Liveblog, your ultimate resource for real-time updates and insightful analysis on a prominent stock. Keep track of Dr Reddys with the latest details, including: Last ...

Hindustan Unilever Ltd., Dr Reddy's Laboratories Ltd., Tata Consultancy Services Ltd., Bharat Electronics Ltd., Kalpataru ...

Lenacapavir is an antiretroviral medicine that helps prevent 99.9 per cent of all HIV transmission, according to studies.

Chandan Taparia has recommended two stocks to buy today – Bharat Electronics (BEL) and Dr Reddy’s Laboratories shares – and ...

Top gainers on the Nifty included Tata Motors, Trent, Bajaj Finserv, SBI, and Dr. Reddy's Laboratories. On the flip side, Hero MotoCorp, Bajaj Auto, Bajaj Finance, IndusInd Bank, and Apollo Hospitals ...

A key downside risk for the company in the near term is tariff announcement given its presence in the United States.

Oprah Winfrey and Elon Musk endorsed it. And though Indian celebrities haven’t yet admitted to their use, the mystery ...

Dr. Reddy's Laboratories Ltd. closed 6.60% below its 52-week high of 1,420.20 rupees, which the company achieved on August ...

Now trading at a price of $15.54, Dr. Reddy's Laboratories Ltd has moved 0.0% so far today. Dr. Reddy's Laboratories Ltd ...

In recent trading, shares of Dr. Reddy's Laboratories Ltd. (Symbol: RDY) have crossed above the average analyst 12-month target price of $15.40, changing hands for $15.53/share. When a stock ...

On June 5, HSBC upgraded Dr. Reddy's Laboratories Limited (NYSE:RDY) from Buy to Hold, raising the price target to INR1,445 from INR1,235, citing an optimistic outlook for the company in terms of ...